ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)
SEK 20.6
(-4.63%)
SEK 20.6
(-4.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -100.88 Million | -99.61 Million | -45.64 Million | -18.17 Million | -12.69 Million | -12.87 Million |
| Net Income | -105.96 Million | -127.6 Million | -48.39 Million | -31.19 Million | -18.11 Million | -18.25 Million |
| Depreciation & Amortization | 1.59 Million | 1.21 Million | 1.8 Million | 2.91 Million | 2.87 Million | 2.61 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -8.69 Million | 14.41 Million | -12.33 Million | 10.91 Million | 1.47 Million | 1.84 Million |
| Other non-cash items | 2.43 Million | 12.36 Million | 13.27 Million | -807 Thousand | 1.07 Million | 913 Thousand |
| Investing Cash Flow | -2.01 Million | 105.32 Million | -100.92 Million | -1.07 Million | -679 Thousand | -813 Thousand |
| Investments in PPE | -2.01 Million | -383 Thousand | -715 Thousand | -885 Thousand | -679 Thousand | -813 Thousand |
| Acquisitions | - | - | 682 Thousand | -194 Thousand | -1.82 Million | - |
| Investment purchases | - | - | -682 Thousand | -194 Thousand | -1.82 Million | - |
| Sales/Maturities of investments | - | - | 682 Thousand | 388 Thousand | - | - |
| Other Investing Activities | - | 105.7 Million | -100.88 Million | -194 Thousand | 1.82 Million | - |
| Financing Cash Flow | 47.83 Million | 61.46 Million | 74.54 Million | 123.38 Million | 12.57 Million | 18.58 Million |
| Debt repayment | -3.86 Million | -1.79 Million | -1.36 Million | -3.17 Million | -5.23 Million | -328 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 60.71 Million | 75.96 Million | 83.3 Million | 143.18 Million | 8 Million | 19.26 Million |
| Other Financing Activities | 46.37 Million | -12.7 Million | -7.39 Million | -16.62 Million | 9.8 Million | -675 Thousand |
| Accounts receivables | 8.62 Million | -8.18 Million | -1.35 Million | -336 Thousand | -43 Thousand | -228 Thousand |
| Accounts payables | -17.32 Million | 22.59 Million | -10.98 Million | 11.24 Million | 1.51 Million | 2.07 Million |
| Inventory | - | - | 10.98 Million | -11.24 Million | -1.51 Million | - |
| Other working capital | -17.32 Million | -1.00 | -10.98 Million | 11.24 Million | 1.51 Million | 2.07 Million |
| Cash at beginning of period | 110.97 Million | 37.11 Million | 106.83 Million | 5.41 Million | 6.25 Million | 1.5 Million |
| Cash at end of period | 57.59 Million | 110.97 Million | 37.11 Million | 106.83 Million | 5.41 Million | 6.25 Million |
| Capital Expenditure | -2.01 Million | -383 Thousand | -715 Thousand | -885 Thousand | -679 Thousand | -813 Thousand |
| Effect of forex changes on cash | 1.68 Million | 6.69 Million | 2.3 Million | -2.71 Million | -42 Thousand | -147 Thousand |
| Net cash flow / Change in cash | -53.37 Million | 73.86 Million | -69.72 Million | 101.41 Million | -837 Thousand | 4.74 Million |
| Free Cash Flow | -102.9 Million | -99.99 Million | -46.36 Million | -19.06 Million | -13.37 Million | -13.69 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -20.69 Million | -14.17 Million | -20.59 Million | -105.96 Million | -22.16 Million | -33.23 Million |
| Depreciation & Amortization | 448 Thousand | 392 Thousand | 409 Thousand | 1.59 Million | 430 Thousand | 433 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 6.77 Million | 16.52 Million | -5.4 Million | -8.69 Million | 10.59 Million | -2.82 Million |
| Other non-cash items | 1.36 Million | -2.81 Million | 7.83 Million | 2.43 Million | -1.13 Million | 1.52 Million |
| Investing Cash Flow | 21.38 Million | -189 Thousand | -19 Thousand | -2.01 Million | -25 Thousand | -747 Thousand |
| Investments in PPE | -678 Thousand | -189 Thousand | -19 Thousand | -2.01 Million | -25 Thousand | -747 Thousand |
| Acquisitions | 22.06 Million | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 22.06 Million | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 353 Thousand | -128 Thousand | -2.59 Million | 47.83 Million | 2.63 Million | 47.08 Million |
| Debt repayment | -225 Thousand | -128 Thousand | -2.41 Million | -3.86 Million | -495 Thousand | -482 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 60.71 Million | 3.38 Million | 57.33 Million |
| Other Financing Activities | 353 Thousand | - | -2.46 Million | 46.37 Million | -250 Thousand | -9.77 Million |
| Accounts receivables | 1.47 Million | -3.2 Million | 102 Thousand | 8.62 Million | 3.26 Million | 6.51 Million |
| Accounts payables | 5.3 Million | - | - | - | 7.32 Million | -9.33 Million |
| Inventory | - | - | - | - | -908.5 Thousand | 9.33 Million |
| Other working capital | 5.3 Million | 19.72 Million | -5.5 Million | -17.32 Million | 908.5 Thousand | -9.33 Million |
| Cash at beginning of period | 60.2 Million | 57.59 Million | 77.18 Million | 110.97 Million | 88.3 Million | 71.97 Million |
| Cash at end of period | 68.55 Million | 60.2 Million | 57.59 Million | 57.59 Million | 77.18 Million | 88.3 Million |
| Capital Expenditure | -678 Thousand | -189 Thousand | -19 Thousand | -2.01 Million | -25 Thousand | -747 Thousand |
| Effect of forex changes on cash | -838 Thousand | 2.06 Million | -1.99 Million | 1.68 Million | -1.45 Million | 4.1 Million |
| Net cash flow / Change in cash | 8.34 Million | 2.6 Million | -19.58 Million | -53.37 Million | -11.12 Million | 16.33 Million |
| Free Cash Flow | -13.23 Million | 665 Thousand | -14.99 Million | -102.9 Million | -12.3 Million | -34.85 Million |
TKOMY
8424
GPTINFRA
002840
BKHT
SDWHF